About one in ten babies need some form of help in the first few minutes after birth to stimulate breathing and to ensure the heart is beating properly. That adds up to a staggering 80,000 babies in the UK, more than 200 each day, and 14 million worldwide each year. The heart rate of the baby is critical for guiding the stabilisation or resuscitation process; however current monitoring methods do not always provide an early enough or sometimes an accurate enough heart rate. This can lead to uncertainty in the management of the baby’s care.

The SurePulse VS is a heart rate monitor aiming to provide accurate and rapid measurements which benefit clinical staff by enabling them to make confident decisions more quickly and to focus on performing procedures in time critical situations. This may help reduce the time patients spend in neonatal intensive care and reduce costs for healthcare organisations.

Read our case study on SurePulse here.